Trial intelligence / Profile preview

Intravenous lidocaine infusion during laparoscopic gastric bypass: effects on postoperative pain and nausea/vomiting

IRCT2015121924754N2Phase 3Completed

Sponsor
Iran University of Medical Sciences
Start
Dec 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of lidocaine in obesity, sponsored by Iran University of Medical Sciences. Primary endpoints: Postoperative pain intensity and Postoperative nausea and vomiting. Started Dec 2014; status: completed.

02

Drugs

lidocaine
03

Conditions

obesity

Beyond the preview

Go deeper on IRCT2015121924754N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2015121924754N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call